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Tempora mutantur, nos et mutamur in illis.
Times change, and we change with them.
                         Owen’s Epigrammata, 1615
Globalization, population demographics, and biotechnol-
ogy are examples of change drivers that influence our social
lives, businesses, and government. These forces create a
changing environment to which organizations must adapt.
Change drivers also affect our health-care system and were
reflected in the themes of this decennial conference.
In 1970, the rising cost of medical care in the fee-for-
service environment was a major change driver. Risk
management also became an important force, in response to
the increase in medical malpractice claims and awareness
that health care-associated infections could lead to litigation.
In 1970, reducing the frequency of both endemic and epidemic
hospital infections was emphasized, as well as emerging
pathogens and antimicrobial-drug resistance (1).
Ten years later, health-care economics was still an
important force, this time manifest by the onset of prospective
reimbursement and diagnosis-related groups as the basis for
payment. In addition, standards for hospital accreditation
relevant to infection control had a major impact on the
profession. The 1980 themes included the critical role of
surveillance and infection control personnel in preventing
infection and the importance of risk stratification in
interpreting infection rates (2).
By 1990, the broadening market penetration of managed
care and the reduced emphasis on hospital in-patient care
were key change drivers. The effects of the “quality assurance
movement” were also evident, along with the enormous
impact of the HIV epidemic. A major theme in 1990 was
increasing severity of illness and hence, increasing infection
risk among hospital patients (3). For the first time, infections
in nonhealth-care settings received attention, as well as
occupational infections, including HIV and other bloodborne
pathogens.
Among many factors influencing the profession of health-
care epidemiology and infection control in the 1990s, three
were deemed to have the most potent impact: health-care
value purchasing, the increasing complexity of health-care
systems and health care, and advances in medical
information technology. Hence, three major themes emerged:
accountability, or demonstrating the attributable impact of
infections and the cost-effectiveness of prevention interven-
tions; extension of health-care quality promotion and
infection prevention programs to include the entire health-
care delivery system; and innovative uses of medical
informatics to enhance the overall impact of our profession.
Health-Care Value Purchasing
Health-care expenditures are once again increasing at an
alarming rate, despite extensive efforts to control costs
through managed care and other strategies. Consumers,
third-party payers, and politicians are demanding that the
delivery system be accountable for the value of these
expensive purchases. Health-care value in simple terms is
directly proportional to quality and inversely proportional to
cost. Ideally, the goal is to obtain the highest quality health
care at an affordable price. From the business perspective, as
the cost of health care per covered employee life increases,
corporate profit margins shrink. Investments in high-quality
prevention and care services that reduce the need for more
expensive care in the future make good business sense for
employers. Hence, many corporations have a strong incentive
to maximize both short- and long-term value of the health-
care benefits they purchase for employees. As a result, large
purchasing coalitions have emerged and now exert
considerable influence on the prevention and treatment
services provided by the health plans they support.
Accountability in Health-Care Quality Promotion
Value purchasing is driving major changes in the delivery
system and new standards for the entire health-care industry.
To survive in this environment, we must first provide the
evidence that quality promotion and infection prevention
programs contribute to health-care value and then help shape
new standards for quality and safety. The first major
conference theme, accountability, is a direct response to the
powerful influence of value purchasing on our profession.
Accountability requires documenting the attributable impact
of health care-associated infections on health-care outcomes
and cost. We must measure the impact of infections on patient
outcomes, satisfaction, and cost of care through credible
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research and use this information to justify goals for
prevention interventions and the need for resources.
Evidence alone is not sufficient to convince decision-
makers that infection prevention is a critical component of
quality promotion and adds value to the delivery system. We
must effectively communicate this information, not only to
our traditional constituents, but also to health-care
administrators, organizations, accreditors, regulators, and
perhaps most importantly, purchasers and consumers.
Effective communication will require some revision in our
vocabulary and a “multilingual” approach that includes
concepts traditionally embraced by other disciplines.
Health-care epidemiologists and infection control profes-
sionals are in the business of infection prevention. Quality
managers and accreditors are in the business of continuous
quality improvement. Health-care purchasers and consumers
are in the business of promoting patient safety and health-
care value. Each of these three groups has its language
(Table), but essentially all are talking about the same things.
“Nosocomial” is a word with a precise meaning that
remains obscure to many within the health-care system and
to most outside of it. “Surveillance” is another term that
effectively communicates an important concept within our
profession but has completely different meanings outside the
epidemiology and public health community. We accept the
concept that some health care-associated infections are
preventable. However, when this same concept is presented
as “some health care-associated infections are due to medical
errors,” many are not so accepting. Until we achieve a “no
name, no blame, no shame” atmosphere, “medical error
prevention” perhaps should be framed as “patient safety
promotion.” Words that obscure the problem, miscommunicate
our purpose, or alarm constituents must be avoided if we are
to convince decision-makers to invest in our prevention
programs.
Accountability also requires that the success (or failure)
of quality promotion efforts, including infection prevention
programs, be measured. Proposed measurements of quality
generally encompass three main areas: health-care outcomes
and cost, processes of care that serve as indicators or
surrogates of outcomes, and patient or consumer satisfaction.
Traditional health-care epidemiology has not empha-
sized measurement of outcomes or patient satisfaction. We do
have enormous expertise in measuring processes of care (e.g.,
infection rates, invasive device utilization, antimicrobial-
drug use). In addition, we have considerable experience in
creating scientifically valid performance measures and
benchmarks for intramural or external comparisons. The
National Nosocomial Infections Surveillance (NNIS) system
is perhaps the largest and certainly the longest ongoing
system for monitoring adverse events in hospitals. In the
1990s, rates of infections monitored in NNIS hospitals
declined by >30%, suggesting that NNIS benchmarking is an
effective quality promotion program in facilities that have
invested in the infection control staff necessary for
participation (4). Preliminary data also suggest that
performance measurement, benchmarking, and feedback
systems can improve antimicrobial-drug use and reduce
antimicrobial-drug resistant infections among intensive care
patients. This approach is likely to have broad utility in
preventing adverse events and promoting patient safety in
other domains and venues.
Measuring adverse event rates is most appropriate when
the numerator is not expected, at least in the short run, to be
zero (i.e., when there is a reasonable expectation that an event
occurs often enough to merit attention and is not entirely
preventable). Health care-associated infections certainly fall
into this category, as do many other complications of health
care. From the perspective of those responsible for ensuring
quality care to a population of patients, monitoring and
comparing rates can be extremely helpful in diagnosing the
need for prevention programs at the local level. Likewise,
facilities with rates well below those observed in comparable
facilities serving comparable patients can be confident that
their care is not deficient in that dimension.
However, we must also consider the perspective of the
individual patient, who is much more concerned about the
cause and consequences of his or her infection than with the
facility’s infection rate. Even in facilities with low infection
rates, some individual infections are likely to be preventable.
Overreliance on rates can create complacency and lost
opportunities to learn from these events and prevent them in
the future. The Institute of Medicine report “To Err is
Human–Building a Safer Health System” drew national
attention to the relevance of this perspective and has
legitimized the value of assessing the causes of individual
adverse events, errors, and near-misses (5). Likewise, the
Joint Commission on Accreditation of Health-Care Organiza-
tions requires facilities to investigate sentinel events, identify
their root causes, and take action to prevent them in the
future (see URL: www.jcaho.org/sentinel/sentevnt_frm.html.)
Complexity of the Health-Care Delivery System
An elderly patient admitted to a hospital with severe
community-onset pneumonia may be evaluated in the
emergency department, visit the radiology department for a
state-of-the-art imaging procedure, and then be admitted to
the intensive care unit for mechanical ventilation. Once
stable, the patient could have a brief stay in a step-down unit
before being transferred to a medical ward. Movement from
one room to another or from one ward to another is likely
because bed or room changes often are needed to
accommodate staffing shortages or isolation room require-
ments. As soon as possible, the patient will be transferred to
a skilled nursing facility and then finally, if all goes well, to
home care or home with ambulatory care follow-up. Along the
Table. Perspectives on health-care quality
 Continuous
  Infection     quality     Patient
Perspective     control improvement       safety
Focus Adverse Indicators Errors,
 health  near misses
 events
Determinants Risk factors Patient mix Root cause,
 human factors
Monitoring Surveillance, Performance Reporting,
 response  measurement,  learning
 improvement
Goal Prevention Performance System
 improvement  improvement
Key profes- Health-care Quality Systems
  sionals  epidemiologists,  managers,  engineers
 infection control  accreditation  health-care
 professionals  officials  purchasers,
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way, the patient will have contact with many health-care
personnel, including nurses, respiratory therapists, techni-
cians, phlebotomists, dieticians, housekeepers, physicians,
consultants, fellows, house staff, and students. In addition,
the patient will encounter an amazing array of medical
devices and monitors, undergo dozens of laboratory tests, and
receive numerous oral and intravenous medications.
The systems of health-care delivery, for even a fairly
simple problem, are both dynamic and incredibly complex.
Patient transfers and complicated interactions between
patients, personnel, and the processes of care (each allowing
opportunities for adverse events or errors) present formidable
challenges to quality health care and effective intervention
programs. Clearly, the increasing complexity of health care is
a major change driver affecting virtually every domain of our
profession.
Quality Promotion through Infection Prevention
across the Spectrum of Health-Care Delivery
The urgent need for enhanced infection prevention
programs in nonhospital settings has been acknowledged for
more than a decade. However, programs to effectively address
this need have been slow to evolve because of lack of
information about the incidence and impact of infections; lack
of validated methods to monitor infections, antimicrobial-
drug use, and resistance; and lack of evidence to document the
cost-effectiveness of prevention programs outside hospitals.
These deficits can be overcome with research, demonstration
programs, and other creative enterprises. However, some
contributing factors present more difficult challenges: scant
resources for hiring and developing the needed staff; lack of
regulatory and accreditation standards to ensure that truly
effective program components are in place; and perhaps most
importantly, lack of focused leadership and commitment from
professional and governmental organizations.
The complexity of the delivery system demands new
strategies to achieve meaningful improvements in quality
and patient safety. The movement of patients through various
health-care settings provides strong support for integrating
prevention programs to encompass the entire system of care.
Until the patient or patient population, rather than the venue
of care, is seen as the organizing principle for these activities,
effectiveness will be compromised and new prevention
opportunities will be missed. For example, monitoring
programs may need to measure not only the use of
antimicrobial drugs in the intensive care unit, but also their
use in patients with diabetes or in geriatric patients as they
move in and out of various venues of care. If trends toward
increased integration of care continue, then integrating infection
prevention and quality promotion efforts will be essential.
Information Technology
The computer age slowly emerged during the last three
decades. The 1970 proceedings include a paper describing the
use of computer-compatible formats for infection surveillance
(6). By 1980, many hospitals had computerized laboratory
information systems sufficient to conduct some laboratory-
based surveillance and monitor antimicrobial-drug suscepti-
bility. By 1990, systems had evolved to include consideration
of the electronic medical record as a key component of
surveillance and intervention programs. However, the
computer age has clearly given way to the explosive onset of
the information age. In 2000, we have access to more
information than we dreamed possible even 5 years ago, we
can instantaneously exchange that information with anyone,
and we can disseminate useful prevention tools anywhere in
the world. We are enjoying the benefits of a technologic
capacity that far exceeds our own capacity to make effective
use of it, a capacity that will revolutionize our profession.
Quality Promotion through Informatics
Medical informatics is the scientific field that uses
computer technology and communication systems to retrieve,
exchange, and optimize use of biomedical information and
data for making health-care decisions and solving problems.
Computer order entry, on-line decision support, and
immediate feedback about treatment decisions are now
recognized as key opportunities for improving medical care.
With the advent of integrated systems, data repositories, and
robust analytic tools, electronic surveillance for infections,
antimicrobial-drug resistance, and related adverse health
events is a realistic goal.
The technology to create local, regional, national, and
international networks for communicating health informa-
tion and providing decision support already exists. E-mail,
list-serves, and other informal networking strategies are in
wide use. Plans are already under way for integrated state-
based electronic notifiable disease reporting, which includes
electronic laboratory data reporting protocols (See URL:
http://www.cdc.gov/nchs/otheract/phdsc/presenters/nedss.pdf).
Programs to link local users in health-care facilities with local
and state health departments and CDC have received
increasing priority and funding as a component of
bioterrorism preparedness and response activities (See URL:
http://www.phppo.cdc.gov/han/). Creating effective internet-
based bidirectional communication channels between the
health-care delivery system and the public health system is
likely to optimize detection, prevention and control of many
emerging health problems.
A complex system such as health-care delivery involves
factors that interact in a very complicated manner. Reducing
a complex system to its simplest terms (e.g., disease or no
disease, risk factor or no risk factor) is one of the strengths of
epidemiology. However, this approach is not sufficient for
understanding health-care systems and the factors affecting
outcomes. Fortunately, advances in systems engineering,
computer science, and complexity research have produced
new tools for understanding complex systems with important
applications in patient safety and health-care quality
promotion. It is now possible to mine the large data
repositories that contain data from patients, providers,
facilities, and plans to identify important trends, evaluate
outcomes and costs, and detect associations that may lead to
quality promotion interventions. New tools for data mining,
which are adept at handling large and robust data sets and
tolerate missing or sometimes inaccurate data elements,
enhance the feasibility of this process and are already in use
for evaluating emerging infections (7). Use of neural network
analytic software is in its infancy, but several creative
applications have demonstrated its utility, including clinical
prediction rules to aid diagnosis (8,9). These and similar tools
help generate new hypotheses that aid understanding of the
system or lead to evaluation of new intervention targets.366 Emerging Infectious Diseases Vol. 7, No. 2, March–April 2001
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Beyond 2000
Times change, and CDC must change along with them.
The Hospital Infections Program has redefined its mission–to
protect patients, protect health-care personnel, and promote
health-care quality–and initiated a reorganization to more
effectively accomplish its priority program objectives. This
process is reflected in the new name, Division of Healthcare
Quality Promotion, which became effective January 1, 2001.
The name change does not signal an end to more than four
decades of successful infection prevention and control
activities or a new move into “quality.” Rather, it reflects what
always has been true: infection prevention is a critically
important component of quality promotion. To paraphrase
Dr. Richard Wenzel’s statement in 1990, infection control is
the premier program for quality promotion in U.S. hospitals.
It makes no sense to ask whether infection control should
expand to include quality promotion; infection control has,
from its inception, been quality promotion (10).
The core activities in health-care epidemiology and
infection control—cluster and outbreak investigations, case-
control studies to identify risk factors, surveillance and
response, laboratory investigation, intervention efficacy and
effectiveness studies–are tools with broad applicability to
many domains of health-care quality. We can lend these tools
to our colleagues in other disciplines and, in turn, benefit from
their tools–root cause analysis, human factors research,
hazards analysis, economic assessment—as we pursue
common goals. We have a unique opportunity to experience,
and, more importantly, to lead the development of consilience,
the linkage of facts and fact-based theory across disciplines to
create a common basis for new explanation or action, in
health-care quality promotion (11).
First, the experience gained from preventing health care-
associated infections must be generalized to encompass a
broader set of adverse events. The progression is logical: from
catheter-associated infections to device-associated infections
to device-associated complications; likewise, from surgical
site infections to procedure-associated infections to proce-
dure-associated complications; from antimicrobial-drug
resistance to medication complications. Together these three
generic categories–device, procedure, and medication compli-
cations-account for most adverse events and medical errors
that affect patient and provider safety, and hence are priority
targets for quality promotion efforts. Building on the lessons
learned from hospital infection control is one way to achieve
rapid success in preventing these related complications.
Second, multidisciplinary collaborations are essential to
instigate innovative prevention research, identify new
applications for old prevention strategies, maximize synergy
among the broad array of professionals engaged in quality
promotion efforts, minimize overlap, and conserve scarce
resources.
In summary, health-care value purchasing, increasingly
complex health-care systems, and information technology are
the three most important change drivers that influenced the
inter-related themes of the 4th Decennial Conference:
accountability, quality promotion through infection preven-
tion across the health-care delivery system, and medical
informatics. Among the change drivers influencing the
themes of the 5th International Conference may be a societal
mandate for health promotion and health-care access for all.
We can hope that market forces demand that “caring”–for
patients and their providers–assumes the highest value in
health-care purchasing decisions. Until we put the caring
back into the health-care delivery system, we cannot hope to
be successful with any quality promotion effort.
Successful consilience among professionals with comple-
mentary skills and capacities working in concert to solve
quality of care problems would be an exciting future theme.
Prevention “success stories” would be another, perhaps
including such topics as elimination of occupational needle
injuries, complete adherence to immunization guidelines
among patients and providers, and substantial reductions in
the incidence of antimicrobial drug-resistant infections.
Likewise, dramatic reductions in benchmark rates of
infections, other adverse events, and medical errors in all
health-care venues, a sign that successful measurement and
prevention programs have been implemented across the
entire system, would be a wonderful theme for the future.
Finally, we may fervently hope that the 5th Decennial
Conference will celebrate success in accomplishing the single
most important factor necessary to promote health-care
quality—a system that fosters joy and balance in the lives of
health-care providers and the time for them to express their
caring and concern for patients.
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